Spiriva Respimat Spray, Metered
Product Images NDC 0597-0160

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Spiriva Respimat (NDC 0597-0160). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Boehringer Ingelheim Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spiriva 01

Chemical structure of tiotropium bromide monohydrate, the active ingredient in Spiriva Respimat inhalation spray. The diagram shows the molecular arrangement including the bromide ion and hydration component.*

FDA Label Image

Spiriva 02

A line graph showing trough FEV1 change from baseline (in liters) over 48 weeks of treatment comparing Spiriva Respimat and placebo groups. Spiriva Respimat shows an increase in FEV1 values, while placebo shows a slight decrease. The graph includes sample sizes for each group and notes adjustments for center, smoking status, and baseline values.*

FDA Label Image

Spiriva 03

A line graph showing FEV1 response (in liters) over 24 hours following drug administration, comparing placebo, Salmeterol 100 mcg, and Spiriva Respimat 2.5 mcg. The x-axis represents time since drug administration in hours, and the y-axis shows FEV1 response in liters. Spiriva Respimat shows a higher and sustained FEV1 response compared to placebo and Salmeterol.*

FDA Label Image

Spiriva 04

An instructional diagram showing two Spiriva Respimat metered inhalation sprays with labeled parts including mouthpiece, air vent, dose-release button, safety catch, clear base, piercing element, and cartridge. The Aqua cartridge delivers 2.5 mcg per puff, two puffs once daily; the Blue cartridge delivers 1.25 mcg per puff, two puffs once daily, illustrating different dosing strengths and color-coded cartridges.*

FDA Label Image

Spiriva 05

An instructional illustration showing the dose indicator of a Spiriva Respimat inhaler. The diagram labels the dose indicator scale with sections marked for 'Full' and 'Empty' to demonstrate how the user can check the remaining doses in the inhaler.*

FDA Label Image

Spiriva 06

An instructional diagram showing how to handle a Spiriva Respimat inhalation spray. The left side illustrates removing the safety catch from the clear base, while the right side shows a person writing the discard-by date on the inhaler.*

FDA Label Image

Spiriva 07

An instructional illustration showing how to prepare the Spiriva Respimat inhaler for use. It demonstrates inserting the narrow end of the cartridge into the inhaler and pressing down firmly until a "click" is heard to secure the cartridge.*

FDA Label Image

Spiriva 08

An instructional illustration showing a person holding a Spiriva Respimat inhaler with a focus on the clear base. The image depicts the action of pressing or sliding the device, highlighting the clear base component of the tiotropium bromide inhalation spray metered dose inhaler.*

FDA Label Image

Spiriva 09

Instructional illustration showing a person using Spiriva Respimat inhalation spray. The image highlights the turning motion of the base with an arrow indicating direction and labels an indicator window marked as 'Arrows' on the device.*

FDA Label Image

Spiriva 10

An instructional illustration showing how to remove the cap from a Spiriva Respimat inhaler spray device by rotating it, with the cap labeled clearly. The image highlights the device held in hand and the cap being detached.*

FDA Label Image

Spiriva 11

An illustration showing a hand pressing the dose-release button on a Spiriva Respimat inhalation spray device. The image includes labeled instructions to repeat steps 4-6 three more times, demonstrating use of the metered-dose inhaler for tiotropium bromide administration.*

FDA Label Image

Spiriva 12

Instructional illustration showing hands demonstrating how to prepare or use Spiriva Respimat inhalation spray. The image highlights arrows on the device indicating the direction to turn or operate, emphasizing the rotational movement needed for proper use of the metered dose spray.*

FDA Label Image

Spiriva 13

An instructional illustration showing how to open the cap on the Spiriva Respimat inhalation spray device, with a hand lifting the green cap upward away from the white inhaler body, indicated by a curved arrow and label "Cap."*

FDA Label Image

Spiriva 14

An instructional illustration showing a person using Spiriva Respimat inhalation spray. The image highlights pressing the top of the inhaler while the mouth is sealed around the mouthpiece, with an air vent labeled on the device. A circle overlay indicates the recommended use of 2 puffs one time each day.*

FDA Label Image

Spiriva 15

FDA Label Image

Spiriva 16

Spiriva Respimat 1.25 mcg/actuation metered inhalation spray packaging label shows the proprietary name and generic name tiotropium bromide inhalation spray. The label includes a depiction of the Respimat Inhaler and cartridge, dosage and usage instructions, storage conditions, warnings, and barcode. The product contains 4 grams for 60 metered inhalations and is distributed by Boehringer Ingelheim Pharmaceuticals, Inc., made in Germany.*

FDA Label Image

Spiriva 17

Packaging label for Spiriva Respimat 2.5 mcg/actuation metered inhalation spray containing 4 grams with 60 metered inhalations. Label shows product name, active ingredient tiotropium bromide inhalation spray, usage instructions, storage precautions, and manufacturer Boehringer Ingelheim Pharmaceuticals, Inc. The label includes a barcode and detailed product contents and warnings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.